Categories Uncategorized

Astiva Health Inc. Championing Culturally Sensitive Healthcare for Aging Asian American Population

  • By 2060, the older Asian population in the U.S. is expected to reach 8.5 million, making up 9% of the country’s elderly demographic, signaling a significant increase from 4% in 2014
  • Astiva Health is leading the charge in creating essential healthcare solutions tailored for this expanding demographic, demonstrating a deep understanding of their unique healthcare needs
  • Astiva Health has introduced groundbreaking programs, including language-specific healthcare services and wellness initiatives, specifically designed for the diverse aging Asian American community

Astiva Health is working serve the Asian American community, which is undergoing a considerable demographic shift, with a growing segment of the population requiring more healthcare and support. The company is proactively meeting the unique needs of this rapidly aging group by providing healthcare services that are culturally sensitive and honor the diverse traditions and values across Asian cultures.

An Urban Institute report highlights the overlooked segment of seniors within the Asian American community facing financial insecurity, despite the broader perception of financial and educational success. This demographic is projected to swell to 8.5 million by 2060, constituting 9% of the U.S.’s older population—a notable increase from its 4% representation in 2014.

Astiva Health’s commitment to culturally sensitive care acknowledges the importance of traditional values such as filial piety and communal living, which are prevalent across various Asian cultures. By offering comprehensive health plans that promote independence while respecting cultural practices, Astiva addresses the challenges of traditional caregiving structures.

Aware of the barriers faced by Asian American seniors, including language difficulties and economic disparities, Astiva Health is dedicated to providing affordable healthcare solutions. The company recognizes the necessity of addressing higher poverty rates among Asian American seniors with targeted interventions.

By investing in the growth of the community, Astiva Health taps into the rich cultural heritage of the Asian American elderly to foster programs that encourage intergenerational exchange and learning. This effort not only enhances the cultural fabric of the communities Astiva serves but also addresses isolation by fostering a supportive community network through initiatives like language-specific healthcare services and senior wellness programs.

As the Asian American population ages, Astiva Health remains at the forefront of tackling the broader societal challenges of aging, healthcare, and cultural integration. With a commitment to delivering high-quality, culturally responsive care, Astiva Health is building a legacy of support for elders from all backgrounds, ensuring they receive the healthcare they deserve. Through strategic initiatives and compassionate care, Astiva Health is shaping a future where the aging Asian American community can thrive with dignity and robust support.

For more information about Astiva Health’s culturally sensitive healthcare solutions, please visit www.AstivaHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to Astiva Health are available in the company’s newsroom at https://ibn.fm/Astiva

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

As Cases of Measles Rise, US Officials Double Down on Contact Tracing and Vaccination

As July came to an end, the United States reached an undesirable milestone: exceeding the…

8 hours ago

Climate Change is Accelerating the Spread of Infectious Diseases, Experts Warn

Scientists and public health experts are warning that climate change is accelerating the rate at which infectious…

4 days ago

Novel Vitamin B12 Treatment Offers Hope in Brain Cancer Treatment

Glioblastoma multiforme (GBM) is the deadliest type of brain cancer and patients usually die within 15 months…

5 days ago

VERAXA Biotech AG (NASDAQ: VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform

The company has appointed antibody therapeutics specialist Dr. Christoph Erkel as Chief Scientific Officer. The…

6 days ago

Regentis Biomaterials Ltd. (NYSE American: RGNT) Builds Commercial and Regulatory Momentum as GelrinC Advances Toward Key Clinical and Regulatory Milestones

Regentis is advancing GelrinC through a pivotal stage of development, with key catalysts including U.S.…

1 week ago

Researchers Plan to Investigate Role of Autoantibodies in Cancer Risk, Immune Response

For a long time, scientists have wondered why many individuals that have several risk factors linked to cancer development never…

1 week ago